Sign In | Join Free | My himfr.com |
|
Ask Lasest Price | |
Brand Name : | ZOSBIO |
Model Number : | 2019-NCoV Neutralizing Antibody |
Certification : | CE BfArm |
Price : | To be negotiated |
Supply Ability : | 10000 Kit/Kit per Day |
Delivery Time : | To be negotiated |
The biosensor is used to detect neutralizing antibodies of New
Coronavirus (2019 ncov) in human serum, plasma and whole blood
samples.
COVID-19 (2019-ncov) β It belongs to New Coronavirus in vivo. It
can cause viral pneumonia. Clinical symptoms include fever,
fatigue, dry cough, etc. some patients have nasal congestion, runny
nose, sore throat, diarrhea and other symptoms. Severe cases of
dyspnea and / or hypoxemia usually occur within a week. Severe
cases will develop rapidly due to acute dyspnea syndrome, septic
shock, maladaptive metabolic acidosis and hemorrhagic dysfunction.
New Coronavirus has many structural proteins such as s, E, m and n.
Spindles include receptor binding domains (RBDS) that recognize the
cell surface. Receptor angiotensin converting enzyme 2 (ACE 2). We
found that RBD of 2019 ncov tattoo protein has a strong interaction
with human ACE2 receptor, which can induce virus replication in
host cells and lungs.
New Coronavirus infection or vaccination can trigger an immune
response and produce antibodies in the blood. After infection, they
will stay in the human circulatory system for months to years. In
order to prevent virus replication, they will quickly and closely
combine with pathogens. This antibody is called neutralizing
antibody. Neutralizing antibody test can determine whether people
have the ability to prevent infection.
The kit consists of a test card and a sample buffer.
Test card: composed of aluminum foil bag, desiccant, test strip and
plastic card. The strip consists of absorbent, nitrocellulose
membrane, sample pad, inner liner and rubber plate. The T-line
(detection line) of nitrocellulose membrane was coated with ACE2
protein, the c-line (quality management line) was coated with
antibody of quality management line, and the R-line (contrast line)
was coated with antibody of large group. The combination pad was
coated with 2019 ncov antigen.
Sample buffer: phosphate, sodium azide, etc
1. Collect serum, plasma or whole blood samples.
2. Precipitates and floats in the sample affect the experimental
results and must be removed by centrifugation.
3. Anticoagulants: Jellyfish skin, EDTA, sodium citrate The use of
anticoagulants has little effect.
4. Blood sampling should be done by a medical professional. Serum /
plasma testing is the first choice. In case of emergency or special
circumstances, the patient's whole blood sample can be used for
rapid examination.
5. The storage time of serum and plasma samples should not exceed 8
hours at room temperature. It can be stored in 2 ° C ~ 8 ° C 6
months, 5 days or less, ~ 20 ° C, but repeated freeze-thaw cycles
should be avoided. Freezing time of whole blood sample should not
be less than 48 hours ℃ -8 ℃.
Please read the guide carefully before the exam. Please lower all
tested drugs to room temperature before testing. The test shall be
conducted at room temperature.
1. Remove the test card from the packaged test bag and use it
within 1 hour.
2. 20 μ Add l sample (serum, plasma or whole blood) into the
filling hole of the test card, and then drop 2 drops (about 60
drops) μ l) Add sample buffer and start timing.
3. The reaction time was 10-15 minutes at room temperature. The
result was invalid after 20 minutes.
Result judgment chart of test card:
1. Invalid results: the quality management line (C line) has no
response line, the test is invalid, and the experiment needs to be
carried out again.
2. Negative results: the detection line (t line) appeared red band,
and its color rendering was higher than that of control line (r
line), quality management line (C line) and control line (r line).
3. Positive results: the test line (t line) had no red band, or the
test line (t line) had red band, but the color development was
lower than that of the control line (r line), and the quality was
decreased. Control line (C line) and control line (r line).
This element is only used for in vitro diagnosis.
2. In order to test, it is necessary to add an appropriate amount
of sample. Too many or too few samples will lead to incorrect
results.
3. Hemolysis, blood lipid, jaundice and contaminated samples may
affect the test results and should be avoided.
4. Reagent test results are only for clinical reference, can not be
used as the only basis for clinical diagnosis and treatment. The
final diagnosis of the disease must be based on a comprehensive
evaluation of all clinical and laboratory results.
1. Specificity analysis
1.1 cross reaction: the following types of antibody evaluation were
conducted for interference with reagents, and no cross reaction
occurred.
SN | Item | Cross reaction | SN | Item | Cross reaction |
1 | Endemic human coronavirus OC43 | No | 10 | Enterovirus | No |
2 | Endemic human coronavirus HKUI | No | 11 | EB virus | No |
3 | Endemic human coronavirus NL63 | No | 12 | Measles virus | No |
4 | Endemic human coronavirus 229E | No | 13 | Human cytomegalovirus | No |
5 | Influenza A virus | No | 14 | Rotavirus | No |
6 | Influenza B virus | No | 15 | Norovirus | No |
7 | Respiratory syncytial virus | No | 16 | Mumps virus | No |
8 | Adenovirus | No | 17 | Varicella-zoster virus | No |
9 | Rhinovirus | No | 18 | Mycoplasma pneumoniae | No |
1.2 interfering substances: in New Coronavirus (2019 ncov) neutralizing antibody test items, the potential interference of the following substances is assessed by adding the following substances in a specific concentration sample. The results show that all kinds of interfering substances will not interfere with the detection results of reagents.
Interfering substances | Concentration | Interfering substances | Concentration |
Bilirubin | ≤50mg/dL | Triglycerides | ≤15mmol/mL |
Hemoglobin | ≤5g/L | Cholesterol L | ≤500mg/d |
Rheumatoid factor | ≤500IU/mL | Human total IgG | ≤14mg/mL |
Ribavirin | 0.4mg/mL | Fluticasone | 0.5mg/mL |
Oxymetazoline | 10mg/mL | Dexamethasone | 5 mg/mL |
Histamine hydrochloride | 10mg/mL | Triamcinolone acetonide | 5mg /mL |
Tobramycin | 1mg/mL | Levofloxacin | 0.2 mg/mL |
Oseltamivir | 1mg/mL | Azithromycin | 0.1 mg/mL |
Zanamivir | 1mg/mL | Ceftriaxone | 0.4 mg/mL |
Arbidol | 0.5mg/mL | Meropenem | 0.2 mg/mL |
2.Clinical study: 120% positive and 300 negative samples were selected from Novell coronavirus (2019 nCoV) IgG test reagents (colloidal gold method) as controls. The results are summarized below.
2019-nCoV IgG Ab detection reagent (colloidal goldmethod) | Sum | |||
Positive | Negative | |||
Positive | 115 | 5 | 120 | |
Negtive | 5 | 295 | 300 | |
Sum | 120 | 300 | 420 | |
Sensitivity | 95.83%, (95%CI: 90.62%~98.21%) | |||
Specificity | 98.33%, (95%CI: 96.16%~99.29%) |
1. This product is used only for in vitro diagnosis.
This product cannot be used after it is thrown away.
3. Before you start, read the operating guide carefully and follow the reagent guide to perform the experiment.
4. Do not conduct experiments in harsh environments such as disinfectants, sodium hypochlorite, acid-base, acetaldehyde, other corrosive gases, and dusty environments. After the experiment, it must be disinfected in the laboratory.
5. All samples and reagents used are considered potentially contagious substances and should be destroyed according to local regulations.
6. Reagents must be used within the shelf life marked on the outer package. Use the induction card as soon as possible to remove it from the aluminum foil bag and prevent moisture.
![]() |